EP 3085783 B1 20210127 - BISPECIFIC ANTIBODY SUBSTITUTING FOR FUNCTIONAL PROTEINS
Title (en)
BISPECIFIC ANTIBODY SUBSTITUTING FOR FUNCTIONAL PROTEINS
Title (de)
BISPEZIFISCHER ANTIKÖRPERERSATZ FÜR FUNKTIONELLE PROTEINE
Title (fr)
ANTICORPS BISPÉCIFIQUES SUBSTITUANT DES PROTÉINES FONCTIONNELLES
Publication
Application
Priority
- JP 0313062 W 20031010
- EP 10180356 A 20041008
- EP 04792180 A 20041008
- JP 2004014911 W 20041008
- JP 0313123 W 20031014
Abstract (en)
[origin: WO2005035753A1] A bispecific antibody substituting for a ligand for a I type interferon receptor comprising two types of molecules having AR1 and AR2 chains is successfully isolated. Further, a bispecific antibody binding to both of blood coagulation factor IX/activated blood coagulation factor IX and blood coagulation factor X and substituting for the function of blood coagulation factor VIII/activated blood coagulation factor VIII enhancing an enzyme reaction is successfully constructed.
IPC 8 full level
C12N 15/09 (2006.01); A61K 39/395 (2006.01); A61P 7/00 (2006.01); A61P 7/04 (2006.01); C07K 16/28 (2006.01); C07K 16/36 (2006.01); C07K 16/46 (2006.01)
CPC (source: EP KR NO US)
A61P 7/00 (2017.12 - EP NO); A61P 7/04 (2017.12 - EP NO); C07K 16/00 (2013.01 - KR); C07K 16/28 (2013.01 - NO); C07K 16/2866 (2013.01 - EP NO US); C07K 16/36 (2013.01 - EP NO US); C07K 16/40 (2013.01 - KR); C07K 2317/24 (2013.01 - EP NO US); C07K 2317/31 (2013.01 - EP NO US); C07K 2317/622 (2013.01 - EP NO US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005035753 A1 20050421; AT E518952 T1 20110815; AU 2003271174 A1 20050427; AU 2004280421 A1 20050421; AU 2004280421 B2 20110602; BR PI0415230 A 20061212; BR PI0415230 B1 20230110; CA 2541671 A1 20050421; CA 2541671 C 20150106; CN 1890369 A 20070103; CN 1890369 B 20170728; DK 1688488 T3 20110926; DK 3085783 T3 20210426; EP 1688488 A1 20060809; EP 1688488 A4 20080305; EP 1688488 B1 20110803; EP 1688488 B9 20120321; EP 2289944 A2 20110302; EP 2289944 A3 20110309; EP 3085783 A1 20161026; EP 3085783 B1 20210127; ES 2370250 T3 20111213; IL 174794 A0 20060820; IL 174794 A 20111130; KR 101361437 B1 20140211; KR 101471194 B1 20141209; KR 20060111497 A 20061027; KR 20130018932 A 20130225; MX PA06003831 A 20060703; NO 20062087 L 20060707; NO 20160762 A1 20060707; NO 338686 B1 20160926; NO 345624 B1 20210518; NZ 546509 A 20100326; PL 3085783 T3 20210719; RU 2006115614 A 20071120; RU 2339696 C2 20081127; SI 3085783 T1 20210730; TW 200514790 A 20050501; TW I354676 B 20111221; UA 95438 C2 20110810; US 2007041978 A1 20070222; US 8062635 B2 20111122; WO 2005035756 A1 20050421
DOCDB simple family (application)
JP 0313062 W 20031010; AT 04792180 T 20041008; AU 2003271174 A 20031010; AU 2004280421 A 20041008; BR PI0415230 A 20041008; CA 2541671 A 20041008; CN 200480036248 A 20041008; DK 04792180 T 20041008; DK 16162353 T 20041008; EP 04792180 A 20041008; EP 10180356 A 20041008; EP 16162353 A 20041008; ES 04792180 T 20041008; IL 17479406 A 20060405; JP 2004014911 W 20041008; KR 20067008860 A 20060508; KR 20127033128 A 20041008; MX PA06003831 A 20041008; NO 20062087 A 20060509; NO 20160762 A 20160506; NZ 54650904 A 20041008; PL 16162353 T 20041008; RU 2006115614 A 20041008; SI 200432510 T 20041008; TW 93130368 A 20041007; UA A200604899 A 20041008; US 57519304 A 20041008